Beckman Coulter launches antibody test with 99.9% specifity

Healthcare Technology
Share

Beckman Coulter has launched its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE mark.

You May Also Like

Healthcare Technology 17-01-2023
Evergreen Nephrology Taps Innovaccer to Transform Kidney Care
Healthcare Technology 20-12-2021
Mental health startup Cerebral teams with Alto Neuroscience to bring ‘precision psychiatry’ to patients’ homes
Healthcare Technology 20-05-2021
3 benefits of therapeutic massage for increased health and relaxation
Healthcare Technology 20-09-2021
University Hospitals Dorset launch patient flow management software
Show CommentsClose Comments

Leave a comment

%d bloggers like this: